Sun Pharma launched INFUGEM injection – a cancer drug in US market
Sun Pharma said INFUGEM uses its proprietary technology which allows cytotoxic oncology products to be premixed in a sterile environment and supplied to the prescribers in ready-to-infuse final dosage bags.
from The Financial ExpressThe Financial Express http://bit.ly/2uRXuld
via IFTTT
from The Financial ExpressThe Financial Express http://bit.ly/2uRXuld
via IFTTT
Post a Comment